Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2Phase 3 1

Status

Active not recruiting 3Recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 6NETWORK 1INDUSTRY 1

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Thoracic 6

Conditions

Breast Neoplasms 2315Neoplasms 1678Prostatic Neoplasms 1178Lung Neoplasms 908Colorectal Neoplasms 873Carcinoma, Non-Small-Cell Lung 848Leukemia, Myeloid, Acute 587Pancreatic Neoplasms 568Multiple Myeloma 542Carcinoma, Hepatocellular 510Brain Neoplasms 509Neoplasm Metastasis 456Head and Neck Neoplasms 454Melanoma 410Ovarian Neoplasms 404Glioblastoma 397Precursor Cell Lymphoblastic Leukemia-Lymphoma 390Stomach Neoplasms 370Uterine Cervical Neoplasms 355Squamous Cell Carcinoma of Head and Neck 355Rectal Neoplasms 336Recurrence 332Hematologic Neoplasms 323Sarcoma 322Colonic Neoplasms 316Lymphoma 310Triple Negative Breast Neoplasms 284Urinary Bladder Neoplasms 279Glioma 277Carcinoma, Renal Cell 277

Interventions

osimertinib 1lorlatinib 1atezolizumab 1Radiosurgery 1Paclitaxel 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
OTHER × Non Small Cell Lung Cancer Metastatic × 1 year × Clear all
NCT06741085 2026-04-13

A Study of Stereotactic Radiosurgery (SRS) and Standard Treatment in People With Lung Cancer That Has Spread to the Brain

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
56 enrolled
Thoracic

Non Small Cell Lung Cancer Metastatic

NCT05853887 2026-03-11

iNUDGE

Abramson Cancer Center at Penn Medicine

Phase NA Active not recruiting
260 enrolled
Thoracic

Non Small Cell Lung Cancer Metastatic

NCT07462728 2026-03-10

Phase III, Multicenter, Randomized Controlled Clinical Study of Three-Dimensional Radiotherapy for Primary Tumors in Non-Oligometastatic Stage IV Non-Small Cell Lung Cancer

Guizhou Medical University

Phase NA Not yet recruiting
200 enrolled
Thoracic

Non Small Cell Lung Cancer Metastatic

NCT03977194 2025-11-18

ELDERLY

Intergroupe Francophone de Cancerologie Thoracique

Phase 3 Active not recruiting
510 enrolled
Thoracic

Non Small Cell Lung Cancer Metastatic

NCT04621188 2025-09-24

Lorlatinib After Failure of First-line TKI in Patients With Advanced ROS1-positive NSCLC (ALBATROS)

Intergroupe Francophone de Cancerologie Thoracique

Phase 2 Active not recruiting
54 enrolled
Thoracic

Non Small Cell Lung Cancer Metastatic

NCT07190677 2025-09-24

NICReWo

Fondazione IRCCS Policlinico San Matteo di Pavia

Recruiting
300 enrolled
Thoracic

Non Small Cell Lung Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡